newsfilter
← Latest News
CNBC·

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior�� to revised Pfizer offer

The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.